NCT07101783View on ClinicalTrials.gov

A Research Study on How a Dose of NNC0662-0419 Works in Japanese, Chinese and Non-Asian Participants Living With Overweight or Obesity

PHASE1RecruitingINTERVENTIONAL

Enrollment

99

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

November 2, 2025

Study Completion Date

November 2, 2025

Conditions

OverweightObesity

Interventions

DRUG

NNC0662-0419

Participants will receive NNC0662-0419 subcutaneously.

Trial Locations (1)

90630

RECRUITING

Altasciences Clinical LA, Inc., Cypress

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY